Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Omeros CorporationNASDAQ: OMER
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt falls 24.8% from a year ago
Net debt stood at $308.73M at the end of Q1 FY2026, down 24.8% from a year earlier and up 34.5% from the prior quarter. Over 3 fiscal years it compounded at -11.5% a year.
Context
- Net debt amounted to 107.9% of total assets at the end of Q1 FY2026, down 66.8 pp from a year earlier.
- Net debt increased in 2 of the last 3 fiscal years.
What to watch
Whether net debt keeps falling in the next quarterly balance sheet after a -24.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- 229.48M USD
- Year-over-year change
- +12.7%
- 4-year CAGR
- -1.8%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 229.48M | +12.7% |
| FY2024 | 2024-12-31 | 203.62M | -42.6% |
| FY2023 | 2023-12-31 | 354.48M | +7.1% |
| FY2022 | 2022-12-31 | 331.01M | +34.0% |
| FY2021 | 2021-12-31 | 247.03M | — |
Net Debt vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's Mar 2026 net debt of $308.73M is the highest of the 11 companies compared; the peer median is -$19.76M.
- Its year-over-year change of -24.8% is the 9th highest of 11, against a peer median of +30.4%.
- Net debt amounts to 107.9% of total assets for OMER, versus a peer median of 11.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $308.73M | -24.8% | -11.5% | 107.9% | |
| Jun 2026 | $96.83M | +82.1% | +45.7% | 8.8% | |
| Jun 2026 | $59M | -53.1% | — | 15.9% | |
| Mar 2026 | $28.89M | +134.8% | — | 8.8% | |
| Jun 2026 | $20.55M | -12.5% | +186.4% | 2.8% | |
| Mar 2026 | -$9.5M | +19.5% | — | 6.5% | |
| Mar 2026 | -$30.01M | +72.2% | — | 13.8% | |
| Jun 2026 | -$36M | +74.1% | — | 3.9% | |
| Mar 2026 | -$36.22M | +41.3% | — | 89.2% | |
| Mar 2026 | -$39.27M | -921.0% | — | 15.5% | |
| Mar 2026 | -$72.7M | +2.8% | — | 18.0% | |
| Peer median (excluding OMER) | -$19.76M | +30.4% | +116.0% | 11.3% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 100.81M | 11.01M | 7.11M | 3.4M | 9.66M |
| Short-term Investments | 56.46M | 183.91M | 164.74M | 86.73M | 162.14M |
| Net Receivables | 82.47M | 242.02M | 6.72M | 36.82M | 36.27M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 67K | 6.3M | 30.75M | 7.17M | 7.6M |
| Total Current Assets | 247.96M | 443.24M | 217.9M | 134.12M | 215.67M |
| Property, Plant & Equipment (Net) | 30.01M | 23.25M | 20.58M | 17.64M | 12.48M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 141.31M | 124.48M | 139.79M | 125.32M | 97.49M |
| Total Non-current Assets | 171.31M | 147.73M | 160.37M | 142.96M | 109.97M |
| Total Assets | 419.27M | 590.97M | 378.27M | 277.08M | 325.63M |
| Account Payables | 13.4M | 5.99M | 7.71M | 5.91M | 4.76M |
| Short-term Debt | 0 | 94.38M | 8.58M | 21M | 17.06M |
| Tax Payables | 338K | 4.87M | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 2.47M |
| Other Current Liabilities | 3.71M | 7.82M | 0 | 29.51M | 30.9M |
| Total Current Liabilities | 51.79M | 136.38M | 53.32M | 79.53M | 78.06M |
| Long-term Debt | 313.46M | 220.91M | 329.71M | 166.58M | 208.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.12M | 125.57M | 2.09M | 200.11M | 153.02M |
| Total Non-current Liabilities | 343.7M | 368.9M | 349.94M | 380.16M | 368.8M |
| Total Liabilities | 395.49M | 505.29M | 403.25M | 459.69M | 446.86M |
| Common Stock | 626K | 628K | 611K | 580K | 716K |
| Retained Earnings | (683.13M) | (635.72M) | (753.53M) | (910.35M) | (913.7M) |
| Accumulated OCI | 0 | 0 | (0) | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 23.78M | 85.68M | (24.98M) | (182.61M) | (121.23M) |
| Total Debt | 347.84M | 342.02M | 361.58M | 207.02M | 239.14M |
| Net Debt | 247.03M | 331.01M | 354.48M | 203.62M | 229.48M |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.